SHFA
KOSP

SS&H Financial Advisors’s K O S PHARMACEUTICALS INC KOSP Stock Holding History

SS&H Financial Advisors’s Portfolio KOSP Stock Details KOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$3.09M Sell
30,525
-300
-1% -$30.4K 1.42% 20
2022
Q4 		$3.38M Sell
30,825
-10,000
-24% -$1.1M 1.61% 15
2022
Q3 		$3.95M Buy
+40,825
New +$3.95M 2.04% 11

SS&H Financial Advisors's KOSP Position: Q1 2023 in Review

SS&H Financial Advisors reduced its K O S PHARMACEUTICALS INC (KOSP) stake by 0.97% in Q1 2023, selling an estimated $30.4K and leaving 30,525 shares worth $3.09M. The position accounts for 1.42% of the portfolio, ranked #20.

SS&H Financial Advisors first reported a position in KOSP in Q3 2022 and has held it in 3 quarters since. The position peaked at $3.95M in Q3 2022. 1 fund tracked by Wall St. Rank holds KOSP as of Q1 2023.

  • SS&H Financial Advisors held 30,525 shares of K O S PHARMACEUTICALS INC worth $3.09M as of Q1 2023.
  • SS&H Financial Advisors sold 300 K O S PHARMACEUTICALS INC shares in Q1 2023, an estimated $30.4K.
  • K O S PHARMACEUTICALS INC made up 1.42% of SS&H Financial Advisors's portfolio in Q1 2023, its #20 holding.
  • SS&H Financial Advisors first reported a position in K O S PHARMACEUTICALS INC in Q3 2022 and has held it in 3 quarters since.
  • SS&H Financial Advisors's K O S PHARMACEUTICALS INC position peaked at $3.95M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held K O S PHARMACEUTICALS INC as of Q1 2023.

Based on SS&H Financial Advisors's 13F filing for Q1 2023, filed 4 May 2023.